Its going to be interesting what they have to say about the Alzheimers results at the conference. Its unusual to piggy back like this off of strong results. I can only see more positive data being disclosed as a way to help promote the treatment.
Place your long positions now, ahead of BOTH, Biogen's presentation at the
American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 – 25, 2015 AND earnings report on 4/24/15.
They will most likely provide updated data.
Don't be a bystander.
Closed at $425.65 on Friday and now the asking price in pre-market is $512.90. Oh my GOD it is going to open sharply sharply higher. Time to buy more or buy a Mutual Fund with BIIB as a major holding. WOW!
Sentiment: Strong Buy
There really is no greed here. Stocks like BIIB (and the other majors) are just doing extraordinarily well. They are just blowing out their numbers consistently. This is the only true growth engine in America today.
Buy all you can BEFORE next earnings and before the next presentation at
American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 – 25, 2015
or buy a lot of the IBB etf calls.
We all know this will pop more...even if we know what to expect. Greed knows no bounds.
You ought to stick to your original plan to try to scare people out of the stock through the boring and predictable "bubble" talk. When you introduce liquidation into a conversation with a company like BIIB or any of the majors its flat out not realistic nor believable. Its like saying MRK or PFE is going to liquidate - not one person's going to listen to you.
You're high. No evidence of short covering whatsoever. Its at support. Thats where stocks are BOUGHT. Your claim has no merit until support is clearly broken. An afternoon sell off that results in a 1% gain on a down day is hardly a victory lap for the bears.
Tomorrow a Reverse split on a low cap OTC Stock. Read my words this stock will be high flyer... and is the MSFT on the Biotec Science.... NVIV.. do your own research and get on board before is to late. Clinical Trials on this NVIV Scaffold is succeeding and FDA giving Green light to more recipients.
Since it is OTC stock the reverse split won't show at the boards like other stocks TRIL, CIM... but NVIV will be trading on Nasdak around April 19.,2015 up-listing... Mutual Funds and Big guys will be loading sooner or later, once it start showing on the different Boards as Nasdak stock.
I AM holding BIIB at 460.. but BIIB will be high flyer with the Alzheimer's drug.... that is the reason I got in on BIIB.. long term
Sentiment: Strong Buy
The chickens got scared out of their short positions today. The biotechs gave up most of their gains into the close. The liquidation phase is coming shortly. Not going to pretty. Unless you got puts and/or short.